- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: beta-II-agonist, inhale steroid
Total 4782 results
-
Astellas Pharma China, Inc.CompletedHealthy Chinese VolunteersChina
-
National Institute of Mental Health (NIMH)RecruitingPerimenopause-Related DepressionUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Imperial College LondonAstraZenecaCompleted
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)Withdrawn
-
Astellas Pharma IncCompleted
-
Otto MuzikUnknownBrown FatUnited States
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM178Japan
-
AstraZenecaCompleted
-
Theodore R. Brown, MD MPHAstellas Pharma IncCompletedMultiple SclerosisUnited States
-
Baylor College of MedicineCompletedUreteral Obstruction | Flank PainUnited States
-
Assistance Publique - Hôpitaux de ParisAssociation Française contre les Myopathies (AFM), ParisCompletedHeart Failure | Duchenne Muscular Dystrophy | CardiomyopathyFrance
-
University of California, San DiegoForest LaboratoriesCompletedHypertension | Pre-hypertensionUnited States
-
Buddhist Tzu Chi General HospitalCompletedUrinary Incontinence | Overactive Bladder Syndrome
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.CompletedHealthy Volunteer | Pharmacokinetics of YM178Taiwan
-
Astellas Pharma IncCompletedHealthy Subjects | Plasma Concentration of MirabegronJapan
-
Henning BundgaardHvidovre University Hospital; Herlev Hospital; Royal North Shore Hospital; Bispebjerg-Frederiksberg... and other collaboratorsCompletedHeart Failure With Reduced Ejection Fraction NYHA Class III-IVDenmark
-
Far Eastern Memorial HospitalWithdrawnOveractive Bladder SyndromeTaiwan
-
GlaxoSmithKlineCompleted
-
Seoul National University HospitalUnknown
-
AstraZenecaCompleted
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States
-
Mylan Bertek PharmaceuticalsCompleted
-
GlaxoSmithKlineCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveKorea, Republic of
-
Clinical Hospital Center ZemunWithdrawnBisoprolol Adverse Reaction | Nebivolol Adverse ReactionSerbia
-
University of MinnesotaForest LaboratoriesCompletedHypertensionUnited States
-
Mayo ClinicCompletedOsteoporosis, Age-RelatedUnited States
-
University of ChicagoForest LaboratoriesCompletedHypertension | DiabetesUnited States
-
Forest LaboratoriesUnknownHypertensionUnited States
-
Vanderbilt UniversityCompletedMetabolic SyndromeUnited States
-
Creighton UniversityWithdrawn
-
Forest LaboratoriesCompletedStage 2 Hypertension | Stage 1 HypertensionUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | Lung DiseaseUnited Kingdom
-
Université de SherbrookeLaval UniversityCompleted
-
Forest LaboratoriesMylan LaboratoriesTerminated
-
Mylan Bertek PharmaceuticalsCompletedHypertensionUnited States
-
Giulio StefaniniAgenzia Italiana del FarmacoActive, not recruitingLymphoma, Large B-Cell, Diffuse | Breast Cancer | Chemotherapy Effect | Cardiotoxicity | Left Ventricular DysfunctionItaly
-
Forest LaboratoriesCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
University of California, San DiegoRecruiting
-
Ain Shams UniversityRecruiting
-
National Taiwan University HospitalCompletedRecurrence of Overactive Bladder SyndromeTaiwan
-
Astellas Pharma IncCompleted
-
Oregon Health and Science UniversityActive, not recruitingObesity | Cardiovascular Risk Factor | Circadian DysregulationUnited States
-
Jagiellonian UniversityUniversity Hospital in KrakowNot yet recruiting
-
Philip KernNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Astellas Pharma China, Inc.CompletedUrge Incontinence | Overactive Bladder (OAB)China